Introduction
============

Pain is one of the most serious medical problems encountered today. Chronic pain, characterized by its long duration, slow recovery and difficulty to control in clinical practice, makes it even more serious than acute pain both physically and psychologically. It is thus an imperative and formidable task for researchers to demonstrate the mechanisms of chronic pain and find effective therapy for its treatment. Transcutaneous electrical nerve stimulation (TENS), which has been developed in the past 30 years, is now being used more and more extensively for pain relief ([@B1]).

Early studies of TENS-induced analgesia mainly focused on the immediate effect induced by single treatment ([@B1]). It has been demonstrated that frequency, intensity, electrode placement and pulse duration are the important impact factors on the TENS effect ([@B2; @B3; @B4]). However, clinical data indicate that repeated electrical stimulation could produce cumulative (long-term) effect ([@B5],[@B6]). The optimal parameters found from acute tests may not be applicable in cases with chronic pain. It has drawn more and more attention to find the suitable parameters for the therapeutic efficacy of multiple TENS treatments ([@B7; @B8; @B9]). Among many factors, the less well-characterized parameter is the time interval between two consecutive sessions of TENS, which played an important role in the outcome of long-term effect in normal rats (W. Xu, PhD thesis, Department of Physiology, Beijing Medical University, Beijing, China, 1995). In the present study, we characterized the optimal interval and intensity of repeated 100 Hz TENS for the treatment of chronic hyperalgesia induced by injecting a small amount of water-in-oil type complete Freund\'s adjuvant (CFA) into single ankle joint in rats.

A great deal of evidence indicates that substance P (SP) as a neurotransmitter or neuromodulator is involved in the transmission of nociceptive signals in the spinal cord ([@B10],[@B11]). It has been shown that SP release in spinal cord and peripheral tissue was increased during the development of inflammation ([@B12],[@B13]) and that TENS or acupuncture might alter the noxious nerve stimulation-induced release ([@B14],[@B15]) and production ([@B16]) of SP in the spinal cord, which may be frequency dependent ([@B17]). Whether spinal SP release was altered by repeated 100 Hz TENS was also characterized in the present study.

Methods
=======

Rats
----

Wistar female rats obtained from the Experimental Animal Research Center, Peking University, were used throughout the study. They arrived at a weight of 150--200 g, were housed 4--6 rats per cage with sawdust bedding and given food and water *ad libitum*. Experiments were conducted according to the Ethical Guidelines for Investigation of Experimental Pain in Conscious Animals ([@B18]) and were approved by the local ethics committee for animal research of Peking University.

Indices obtained in the present study were observed and measured by one of the authors (H.-X. L.) throughout the experiments to avoid interobserver differences.

Induction of Monoarthritis
--------------------------

### Preparation of Water-in-Oil Type CFA

Two 1 ml syringes were used, one filled with incomplete Freund\'s adjuvant (IFA) (0.85 ml paraffin oil mixed with 0.15 ml Aracel A in 1 ml, Gibco Company), and another with equal volume of suspension of killed *Mycobacterium tuberculosis* (Human strain, 20 mg ml^−1^, Chinese Inspection Institute for Biological Materials, Beijing). They were interconnected with each other through a plastic catheter of ∼6 cm long. Careful attention was paid to avoid air bubbles in the catheter and syringes. The pistons of the two syringes were pushed alternately until thick water-in-oil emulsion was formed. The preparation of the control IFA was the same as that for CFA with the exception that the suspension of killed *M. tuberculosis* was substituted with normal saline.

### Intra-articular Injection

Intra-articular injection to the tibio--tarsal joint was performed as described by Butler *et al*. ([@B19]). Briefly, rats were anesthetized with 10% chlorohydrate (300 mg kg^−1^, i.p.). Freund\'s adjuvant (30 μl) was injected into the right ankle joint through a 26^1^/~2~-gauge needle inserted into the articular cavity.

Transcutaneous Electrical Nerve Stimulation
-------------------------------------------

The monoarthritic rats were restrained in a specially designed holder with the hind legs and tail exposed. The hair on the lower legs was removed with saturated barium sulfide (BaS) solution and rinsed thoroughly with water. After wiping and drying the legs, two pairs of round platinum electrodes (5 mm diameter) were attached tightly on both legs, one on the normal saline wetted skin of Zusanli (ST36, the lateral side of the anterior tibial tubercle of the leg at the level between upper one-third and lower two-third of the tibia) and another on the medial side at the same level to form a circuitry. The Eight channel HANS stimulator used was manufactured by the Beijing Medical University. The parameters for TENS output were as follows: 0.2 ms pulse width, 100 Hz frequency and 30 min duration per session. The intensity of stimulation was arranged at three levels as follows: weak (1-1-2 mA), medium (1-2-3 mA) or high (2-3-4 mA), with current increasing stepwise, each step lasting for 10 min. For mock stimulation, the skin electrodes were placed on the same regions but no current was delivered. To find the optimal interval of TENS treatment, once-a-week, twice-a-week or five-times-a-week schedule was used with the medium intensity stimulation.

Indices for Behavioral Observations
-----------------------------------

Behavioral observations included body weight, circumferences of the ankle joints bilaterally, leg-withdrawal threshold and scores of arthritic flexion (both plantar and dorsal flexion) pain test. The rats were weighed before putting in the holder. The other measurements were made 30 min after the rats were restrained. These measurements were taken once-a-week before TENS treatment with the observation time allocated in the morning between 8:00 a.m. and 12:00 noontime.

### Measurement of Ankle Circumference

The circumferences of the ankles were measured around the lower edge of lateral and medial malleolus with a flexible ruler without elasticity.

### Measurement of Leg-withdrawal Threshold

Randall--Selitto response was determined with continuously increasing pressure applied on one side of the ankle joint. The value of pressure (mm Hg) was recorded at the withdrawal of the leg. The mean value of two measurements with a 30 min interval was taken as the final result of the paw withdrawal threshold. The threshold of the contralateral side was examined 15 min later.

### Scoring of Arthritic Flexion Pain Test

The ankle joint was gently flexed to the plantar direction for 5 times with an interval of 5 s. The same manipulation was used and the force onto the ankle was monitored by the color change of the thumb fingertip induced by blockade of blood circulation. The leg-withdrawal scores were measured, respectively. It was scored zero when rats showed no quick leg-withdrawal; scored 1 when the brisk withdrawal reaction appeared. A total leg-withdrawal score was obtained between 0 and 5 for each test session. The same scoring method was employed for dorsal flexion test, which was proceeded to the extent that the toes touched the front of the leg.

X-ray Examinations
------------------

Radiographic evaluation (40 kV, 2 ms) was performed under light anesthesia based on whole body radiographs and coned-down views of the hind limbs.

Radioimmunoassay of SP
----------------------

Rats were anesthetized with chlorohydrate. A PE-10 catheter was inserted into the subarachnoid space through the cisterna magna with the tip reaching the level of lumbar spinal enlargement. Another piece of polyethylene tube (PE-50) was inserted 10 mm down the cisterna. Artificial cerebrospinal fluid contained bacitracin (30 mg l^−1^), a peptidase inhibitor, was perfused at a rate of 1.0 ml per 30 min with a push--pull pump ([@B20]). The spinal perfusate (1.0 ml) was collected in the Eppendorf vials immersed in an ice-water bath and then heated for 10 min in boiling water bath. After cooling down to room temperature, the perfusate was centrifuged at 10 000 g for 10 min. Supernatants were lyophilized and stored at −20°C.

The lyophilized perfusate was reconstituted in 250 μl H~2~O for the radioimmunoassay (RIA) of SP. ^125^I-SP RIA kits were bought from the Basic Research Institute, Chinese Academy of Medical Sciences, Beijing. The SP antiserum showed no detectable cross-reactivity with ACTH, angiotensin II and Met-enkephalin, \<0.01% with eledoisin, \<0.008% with eledoisin-related peptides. The non-specific binding rate was 6.18%, total binding 35.8% and IC~50~ 112 fmol per tube. Standards (or samples) (100 μl), SP antiserum (1:6500, 100 μl) and \[^125^I\]SP (10000 dpm, 100 μl) were added to the polyethylene test tubes, mixed thoroughly and then incubated for 72 h at 4°C. For the separation of bound from free peptide, 1 ml 0.5% Dextran-T70-wrapped active carbon was added into the above assay system while mixed in an ice-water bath. The mixtures were centrifuged for 20 min at 1750 g, 4°C following 10 min of standstill on bench. The supernatants were counted using micro-γ-counter.

Data Processing and Statistical Analyses
----------------------------------------

The results were presented as mean ± SEM for continuous data (body weight, ankle circumference, withdrawal threshold of pressure to ankle, content of SP-ir) or as median ± median-derived absolute deviation (MAD) for the non-parametric data (pain scores). Continuous data were processed with two-way analysis of variance (ANOVA) followed by Duncan\'s test. For the discrete data (pain scores), Friedman ANOVA (repeated measures ANOVA on ranks) was used to analyze the change of pain scores with the time course within the group, Kruskal--Wallis ANOVA (one-way ANOVA on ranks) followed by Dunn\'s test or Mann--Whitney *U*-test for the comparison between the groups at the same time point. A *P*-value of \<0.05 was considered statistically significant.

Results
=======

Assessment of Monoarthritis as a Chronic Pain Model
---------------------------------------------------

CFA inoculated rats maintained a steady weight increase during the 9 weeks of observation, although the final increment was 9.7% less than the control group (data not shown). The animals appeared active generally.

### Circumference of the Ankle Joint

Swelling of the injected ankles occurred in a few hours after inoculation, and aggravated or even spread to the toes and lower legs in 24 h. It subsided gradually after 48 h, became limited to the ankle in a week, subsided in 3 weeks and maintained at this level for at least 6 weeks ([Fig. 1](#F1){ref-type="fig"}A). A similar but milder response was observed in rats inoculated with IFA. No significant change of the diameter of the contralateral ankle was observed.

### Withdrawal Threshold to Lateral Pressure

Leg-withdrawal thresholds to lateral pressure decreased significantly compared with the IFA-inoculated group or the contralateral side of the same group (*P* \< 0.01, [Fig. 1](#F1){ref-type="fig"}B) at the third week after CFA inoculation. The hyperalgesia maintained for ∼4 weeks, and returned to the normal level by ninth week. No significant reduction occurred in IFA-inoculated group (*P* \> 0.05).

### Leg-withdrawal Scores in Flexion Pain Test

Results obtained from the flexion pain tests revealed that (i) an increase in pain scores occurred only in the ipsilateral side, suggesting a local rather than general lesion; (ii) a similar abrupt increase in arthritic pain appeared in both the CFA- and IFA-inoculated groups, suggesting the development of acute inflammation; (iii) a decrease in pain scores of the IFA group occurred in the third week and disappeared in the fourth week, which was in contrast to the maintenance of high levels of pain scores for at least 9 weeks in the CFA group, suggesting the existence of chronic hyperalgesia ([Fig. 1](#F1){ref-type="fig"}C and D).

### X-ray Examination

A slight narrowing of the joint cavity and roughening of the articular surface of the inoculated ankle was observed 6 weeks after CFA inoculation ([Fig. 1](#F1){ref-type="fig"}E and G). No significant change of the bone density was observed around the joint at 4 and 6 weeks following the CFA injection. No X-ray changes were seen in IFA-injected group at the same time points of observation (data not shown).

### Pathological Study

Pathological study revealed that the arthritis was localized to the site of injection, accompanying swelling of the joint-capsule, narrowing of the joint cavity and roughening of the articular surfaces at 4 and 6 weeks after CFA injection (data not shown).

Optimal Parameters of Repeated 100 Hz TENS for the Treatment of Chronic Inflammatory Hyperalgesia
-------------------------------------------------------------------------------------------------

### Consecutive TENS Treatments with Different Intervals

The schedule for the treatment was once-a-week, twice-a-week or five-times-a-week using the medium intensity stimulation (1-2-3 mA). TENS was administered (i) beginning at 24 h after the injection of CFA, and lasted for 3 weeks for the treatment of acute period of arthritis; (ii) starting at fourth week and extended to ninth week after the intra-articular injection of CFA, for the treatment of chronic period of arthritis. The indices measured include body weight, circumference of the ankle and scores of arthritic flexion pain tests, which were performed once-a-week just prior to the TENS treatment.

### Acute Period of Arthritis

Repeated TENS treatments were delivered at different intervals as follows: once-a-week ([Fig. 2](#F2){ref-type="fig"}: 1A--D), twice-a-week ([Fig. 2](#F2){ref-type="fig"}: 2A--D) and five-times-a-week ([Fig. 2](#F2){ref-type="fig"}: 3A--D) on the acute period of monoarthritis (Weeks 1--3 after intra-articular injection of CFA). The ankle circumference was decreased in the group receiving twice-a-week TENS treatment ([Fig. 2](#F2){ref-type="fig"}: 2B). On the contrary, it increased in the five-times-a-week TENS group ([Fig. 2](#F2){ref-type="fig"}: 3B) compared with the control group. No significant change was observed for other indices ([Fig. 2](#F2){ref-type="fig"}).

### Chronic Period of Arthritis

The results are shown in [Fig. 3](#F3){ref-type="fig"}. When TENS was applied in the stable period of monoarthritis (i) the indices were improved in rats receiving TENS once-a-week as shown by an increase in the body weight at the time point of 5, 6, 7, 8 and 9 weeks after injection of CFA (Duncan\'s test following ANOVA, *P* \< 0.01) ([Fig. 3](#F3){ref-type="fig"}: 1A), a reduction of swelling of the infected ankle ([Fig. 3](#F3){ref-type="fig"}: 1B, two-way ANOVA from fifth week through ninth week), a robust decrease in the flexion pain scores at the sixth week through ninth week (Mann--Whitney *U*-test, *P* \< 0.01 for all) ([Fig. 3](#F3){ref-type="fig"}: 1C and D). (ii) Administered twice-a-week, TENS treatment produced a moderate decrease in the plantar flexion pain score at sixth week through eighth week after injection of CFA (Mann--Whitney *U*-test, *P* \< 0.05) ([Fig. 3](#F3){ref-type="fig"}: 2C). The other three indices did not change significantly ([Fig. 3](#F3){ref-type="fig"}: 2A, B and D). (iii) Applied five-times-a-week, there were no obvious improvements in body weight, ankle swelling and plantar pain test ([Fig. 3](#F3){ref-type="fig"}: 3A, B and C). Rather, the dorsal flexion pain score was slightly higher than mock TENS group at eighth and ninth week after injection of CFA (Mann--Whitney *U*-test, *P* \< 0.05) ([Fig. 3](#F3){ref-type="fig"}: 3D).

TENS Treatments with Different Intensities
------------------------------------------

The rats were inoculated intra-articularly at right ankle and were distributed randomly into four groups as follows: three TENS groups using three levels of intensity (low: 1-1-2 mA, medium: 1-2-3 mA and high: 2-3-4 mA) and the control group. TENS treatment was administered beginning at 24 h after the injection of CFA and lasted for 9 weeks, using once-a-week or twice-a-week schedule.

### Once-a-week

The results are shown in [Fig. 4](#F4){ref-type="fig"}. The low intensity (1-1-2 mA) TENS treatment induced a marked and sustained decrease in the plantar flexion pain test (Friedman ANOVA on ranks, *P* \< 0.01, *P* \< 0.05, respectively). Medium intensity TENS induced a moderate drop of scores of flexion pain test (Friedman ANOVA on ranks, *P* \< 0.05). It is notable that no therapeutic effect was observed with high intensity TENS. The growth rate of body weight and the circumference of the inflamed ankle showed no significant difference between the TENS group and the control group (data not shown).

### Twice-a-week

No significant change of any indices was observed in any TENS group (data not shown).

Suppression of Spinal Release of SP by Repeated 100 Hz TENS
-----------------------------------------------------------

Monoarthritic rats produced by intra-articular injection of CFA at right ankle were randomly distributed into 12 groups, given spinal perfusion at 1, 2, 3, 5, 7 and 9 weeks, respectively, after injection of CFA. At each time point, the TENS (1-1-2 mA, once-a-week) group was accompanied by a control (mock TENS) group. At each time point 3--4 naïve rats were used, in which the above-mentioned indices were measured and spinal perfusate was collected. The results are shown in [Fig. 5](#F5){ref-type="fig"}.

### Observation of the Behavioral Indices

The TENS treatment started from the first week through ninth week. Rats were sacrificed at different stages of the experiment. The results shown in [Fig. 5](#F5){ref-type="fig"}A--C were composed of data obtained from different groups of rats, showing the reproducibility of the TENS efficacy.

The circumferences of the inflamed ankles of rats that received TENS treatments were significantly lower than that of the control group (ANOVA, *P* \< 0.05) ([Fig. 5](#F5){ref-type="fig"}A); the leg-withdrawal scores of arthritic plantar and dorsal flexion pain test were also decreased significantly (Kruskal--Wallis, *P* \< 0.05 and *P* \< 0.01) ([Fig. 5](#F5){ref-type="fig"}B and C). No significant difference of body weight was observed between the TENS group and the control group (data not shown).

### Contents of SP-ir in the Spinal Perfusate

*Significant correlation of spinal SP-ir release and body weight in naïve rats.* [Figure 5](#F5){ref-type="fig"}D shows the regression curve of the contents of SP-ir in spinal perfusate and the body weight in 26 naïve rats. It indicates that within the range of 180--350 g body weight, there was a reduction of the content of SP-ir in spinal perfusate along with the increase in body weight, showing a negative correlation between the two factors (*P* \< 0.05).

*Influences of TENS on the contents of SP-ir in spinal perfusate*. In the control (mock TENS) group, there was a significant decrease in SP-ir content in spinal perfusate at 1 week after the injection of CFA (ANOVA followed by Duncan\'s test, *P* \< 0.05, [Fig. 5](#F5){ref-type="fig"}E), which returned to the level of naïve rats at the second week and then gradually declined with time until the ninth week after CFA injection. In the TENS group, however, a steady gradual decrease in SP-ir content was observed. The decrease became statistically significant at fifth week to ninth week compared with the control value at Week 0. In the period from second week through ninth week, the levels of SP-ir in rats that received TENS treatments were significantly lower than that of the control group (two-way ANOVA, *P* \< 0.05, [Fig. 5](#F5){ref-type="fig"}D).

*Weight-normalized contents of SP-ir in the spinal perfusate.* In order to exclude the influence of the body weight on the contents of SP-ir, we normalized the content of SP-ir according to the regression equation ([Fig. 5](#F5){ref-type="fig"}D) as follows: weight-normalized content of SP-ir = actual content + 0.2557 \[body weight (g) − 200\], where 0.2557 is the regression coefficient and 200 is about the average body weight at the beginning of the experiment. The results are shown in [Fig. 5](#F5){ref-type="fig"}F. In the control rat, there was an abrupt decrease in SP-ir 1 week after the injection of CFA, and then returned to and remained approximately at the level of naïve rats. In the TENS group, there was a mild but significant decrease in SP-ir content, remaining there for the whole observation period of 9 weeks. Comparison between the two curves in the period from second week to ninth week after the injection of CFA showed a statistically significant difference (two-way ANOVA, *P* \< 0.05).

Discussion
----------

In our selection of an inflammatory pain model, we considered various options. The adjuvant-induced polyarthritis has been widely used for the study of chronic arthritic pain since its introduction in 1956 by Pearson ([@B21]). However, the general health condition in these animals could be very bad because of the widespread immunological lesions. Thus, it brings about many biochemical, physiological and behavioral disorders besides pain.

Butler *et al*. ([@B19]) developed a monoarthritic pain model with long-term joint hyperalgesia by injecting CFA via intra-articular route of administration. Following Butler *et al*.\'s procedure using a water-in-oil type CFA, a monoarthritic model was produced in the present study, which fulfilled the following criteria: (i) clear manifestation of joint hyperalgesia, (ii) hyperalgesia was maintained at a plateau for at least 6--9 weeks, (iii) minimal destruction of bone tissue and (iv) no severe change in general health. The general condition of the animals was quite good as shown by the steady increase in body weight. The arthritis manifested two distinct stages. There appeared acute redness and swelling of the joint within hours after the articular injection, which peaked in 24 h and subsided in the third week, whereas the joint hyperalgesia maintained for at least six more weeks. X-ray examinations and pathological study revealed no significant change in the bone density around the site of injection. Thus, it appears to be a convenient model for the study of both acute (in the first 3 weeks) and chronic (4--9 weeks after inoculation) inflammatory hyperalgesia.

The theoretical basis of TENS was established mainly on the gate control concept developed by Melzack and Wall in 1965 ([@B22]), which suggests that activation of large diameter mechanoceptive fibers will presynaptically inhibit the activity of small caliber nociceptive afferents. According to this theory, the optimal sites for placing TENS electrodes should be chosen at the same segmental region as that of the noxious input ([@B23; @B24; @B25; @B26]), and the optimal parameters for TENS should be of low intensity and high frequency for preferential excitation of the large diameter fibers ([@B23]). Indeed, this has been referred to as 'conventional TENS' and extensively used in clinical practice ([@B1]). In contrast to the conventional TENS, electroacupuncture (EA) has often been described as a peripheral conditioning stimulation of high intensity and low frequency, which is delivered heterosegmentally ([@B27],[@B28]). However, Wang *et al*. ([@B29]) found no significant difference in producing antinociception between EA and TENS at three different levels of frequencies (2, 15 and 100 Hz). It was also found that EA and TENS exhibited a profound cross-tolerance when the same frequency was applied, indicating that a similar neurochemical mechanisms may underlie both EA and TENS analgesia. The systemic study on the specificity of acupoint in normal rats using electrophysiological methods showed that the effect of EA was determined by the intensity of EA stimulation, such that weak EA produced a segmental analgesia, while strong EA produced a generalized analgesia ([@B30],[@B31]). TENS may also act through modulating descending influences from supraspinal sites ([@B4]).

Multiple studies have shown that the frequency of TENS stimulation is an important factor for its efficacy on inflammatory hyperalgesia and neuropathic pain ([@B4],[@B32; @B33; @B34; @B35; @B36; @B37]) and mechanisms underlying the effects of high (\>50 Hz) and low (\<10 Hz) frequency stimulation are different ([@B1],[@B33]). We have compared the effects of low (2 Hz) and high (100 Hz) frequency of repeated TENS on the chronic inflammatory hyperalgesia and found that 100 Hz TENS produced better therapeutic effects ([@B38]).

Thus, in the present study we use high frequency (100 Hz) TENS and placed the skin electrodes near the inflammatory region to assure a full extent analgesic effect when different intensities and intervals of TENS were used.

It has been generally accepted that the activation of large diameter (Aα, Aβ) afferent fibers would produce a segmental antinociceptive effects ([@B22]), whereas high intensity (noxious) stimulation would also activate small diameter (Aδ, C) fibers to produce diffuse noxious inhibitory control (DNIC) ([@B31]). In normal rats, peripheral stimulation of 1--3 mA can produce an intensity-dependent increase in tail flick latency, i.e. the higher the intensity, the stronger the analgesic effect ([@B30],[@B31],[@B39; @B40; @B41]). However, Zhu *et al.* ([@B42]) found that in rats with sciatic nerve injury or arthritis, higher intensity EA did not produce a more potent analgesic effect as compared with the low intensity stimulation. In the present study, high intensity (2-3-4 mA) stimulation produced little analgesic effect in contrast to the reduction of pain scoring in the low intensity (1-1-2 mA) group ([Fig. 4](#F4){ref-type="fig"}).

What then are the possible mechanisms underlying this seemingly paradoxical phenomenon? It has been revealed that a series of plastic changes occurred in animals with nerve injury or tissue inflammation ([@B43; @B44; @B45; @B46]). In the inflammatory rat model, there was an increase in the affinity of the opioid receptor and an increase in the excitability of the afferent nerve fibers not only in the spinal dorsal horn but also in many other regions of the central nervous system ([@B47]). There was also an increase in the spontaneous discharge of the spino-thalamic neurons in rats with chronic sciatic nerve injury ([@B48]). One may postulate that the signals induced by EA or TENS may be put through more easily when there is an increase in the excitability of the relevant nerve pathway, so that a weak stimulation is now recognized and processed as a moderate stimulation to produce a proper therapeutic effect, whereas a strong stimulation would be perceived as a suprastrong stimuli thereby exacerbate the hyperalgesia and allodynia. The activation of large diameter primary afferents from deep somatic tissues, not cutaneous tissues, is important in causing TENS analgesia ([@B49]).

The effects of multiple TENS have drawn significant attentions to the researchers ([@B1]). Among many factors, how frequently TENS treatments need to be given for the best outcome is less studied. In the present study we made systemic observations on the therapeutic effects of three different intervals of repeated 100 Hz TENS on the acute and stable period of CFA-induced monoarthritis, and found that for the treatment of acute period of monoarthritis (Weeks 1--3), the optimal interval is twice-a-week; while in the stable period (Weeks 4--9), once-a-week schedule appears to produce better therapeutic effect. When TENS was administered too frequently (five-times-a-week), no therapeutic effect was observed and the swelling of the inflamed ankle may even be aggravated.

Fu *et al*. ([@B50]) used repeated acupuncture stimulations for the treatment of experimental gastric ulcer in rats, and found that every-other-day treatment was the most effective schedule for accelerating the healing of the ulcer. Using weak EA for the treatment of neuropathic pain in the rat it was found that once a day or once every-other-day was most effective to suppress hyperalgesia and allodynia ([@B37],[@B42],[@B51]). Wu *et al*. ([@B52]) used 2/100 Hz TENS for the treatment of heroin withdrawal syndrome in drug addicts and found that in the first 2--3 days of drug abstinence, 3--4 treatments (30 min each) a day were needed to secure best results, which could then be reduced to 3 and then 2 treatments per day in the rest of the 2 week detoxification period. It has also been reported that permanent press auricular acupuncture retained *in situ* for 1 day after surgery reduces the post-operative analgesic requirement after ambulatory knee arthroscopy ([@B53]).

Taken together, the data indicate that diseases with acute syndrome need more frequent EA or TENS treatments as compared with chronic stage which may require more sparse treatments for best therapeutic effect. Also this may help to avoid developing TENS tolerance induced by frequent (daily) treatments ([@B54]).

Involvement of SP in the TENS Treatment on Inflammatory Hyperalgesia
--------------------------------------------------------------------

To study the mechanisms of the therapeutic effect of TENS treatment on inflammatory hyperalgesia, we focused on the possible role played by SP in spinal cord in monoarthritic rats. SP immunoreactivity (SP-ir) in spinal perfusate was measured using RIA. Since the SP converting enzyme does not show an increased activity during the period of arthritis ([@B55],[@B56]), the decreased level of SP-ir in spinal perfusate observed in the present study could be taken as an index for the decreased rate of SP release from the central nervous system, especially from the spinal cord.

Given that the negative correlation between the content of SP-ir in the spinal perfusate and the body weight in naïve rats, which has also been shown in other reports ([@B57]), may serve as the reason of the rundown of the SP-ir contents observed during the TENS treatments, we normalized the SP-ir content in spinal perfusate to exclude the impact of the animal growth (body weight increase) during the observation period of more than 2 months. An abrupt decrease in SP-ir in spinal perfusate was observed 1 week after CFA inoculation in the control rats without TENS, which is consistent with the findings obtained in spinal slices ([@B58]). Also, Sluka and Westlund ([@B12]) reported that during the acute experimental arthritis induced by injection of kaolin and carrageenan into the knee joint there was an initial depletion of SP contents in spinal dorsal horn, presumably because of a massive release of SP from the primary afferents. This may result in a depletion of SP at the spinal dorsal horn, leading to an abrupt decrease in SP-ir in spinal perfusate mentioned above.

It is interesting to note that this abrupt decrease in SP-ir was not observed in the rats receiving TENS treatment. This can be due to (i) the amelioration of inflammatory process by TENS treatment so that the inflammation-induced increase in the central SP release was not so dramatic as in the control group without TENS treatment; (ii) the suppression of SP release from the central terminal of primary afferent by the activation of large diameter afferent fiber through gate control mechanism ([@B22]). Taking the circumference of the ankle joint as an index of the ankle swelling, namely the severity of arthritis, it was obvious that no significant difference was found between the groups with and without TENS at the first week, suggesting that the inflammatory process was not significantly affected by TENS, which is obviously not in favor of the first explanation.

Starting from the second week to the ninth week, the level of SP-ir in the TENS group was significantly lower than the control group, which was in parallel with the temporal course of a significant decrease in pain scores in TENS group. This decrease was obvious in the second week in contrast to the significant improvement in joint swelling occurred only from the seventh week ([Fig. 5](#F5){ref-type="fig"}B and C). Moreover, compared with the strong analgesic effect, the anti-inflammatory effect of TENS as revealed by the reduction of joint swelling is relatively weak. The results appear in favor of the hypothesis that a low intensity transcutaneous electric stimulation (1--2 mA) can produce a marked reduction of chronic hyperalgesia, accompanying with a suppression of the release of SP in the spinal cord. This is similar to the finding that single session TENS (50 Hz, 50 V, 5 min) shows analgesic effects by reducing the production of SP in both the dorsal root ganglion and dorsal horn of the spinal cord ([@B59]). This may add to the emerging evidences that some of the analgesic effects of TENS and acupuncture may be mediated through the alteration of neurotransmitters release, e.g. the release of aspartate, glutamate, glycine ([@B33],[@B37]) and nitric oxide ([@B60]) and serotonergic activity ([@B36],[@B61],[@B62]), as well as the receptor expression, e.g. the opioid receptor ([@B1],[@B33]), alpha2A adrenergic receptors ([@B63]) and muscarinic receptors ([@B3],[@B64]).
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![Behavioral tests and X-ray examination in rats injected intra-articularly with the Freund\'s adjuvant (FA) at the right ankle joint. Ankle circumference (**A**), withdrawal threshold to lateral pressure (**B**) and pain score evaluated by the plantar (**C**) or dorsal (**D**) flexion of the hind paw were examined (*n* = 10 in each group). Whole body (**E**) radiograph and high power view of bilateral ankles of a rat were taken at the sixth week after intra-articular injection of CFA at the right ankle. (**F**) and (**G**) are the enlargements of the left and right ankle joint from E. Ipsi and contra represent the side of ankle joint ipsilateral or contralateral to that receiving intra-articular injection. IFA, incomplete Freund\'s adjuvant; CFA, complete Freund\'s adjuvant. \**P* \< 0.05, \*\**P* \< 0.01 compared with the level measured before the FA inoculation (Week 0). ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 compared with left ankle at the same time point.](nel056f1){#F1}

![Multiple sessions of 100 Hz TENS with twice-a-week schedule reduce joint swelling in the acute period of rat monoarthritis induced by intra-articular injection of CFA at the right ankle. TENS was administered with medium intensity of stimulation (1-2-3 mA), beginning at 24 h after the injection of CFA (shown by arrows on the horizontal bar). For control group, TENS skin electrodes were placed on the same regions of skin but no current was delivered. \*\**P* \< 0.01 (two-way ANOVA between two curves from the first week to the fourth week).](nel056f2){#F2}

![Multiple 100 Hz TENS treatments given once-a-week reduce joint swelling and pain scores in the stable period of rat monoarthritis induced by intra-articular injection of CFA at the right ankle. TENS treatments with medium intensity (1-2-3 mA) were administered from fourth week through ninth week after the injection of CFA (shown by arrows on the horizontal bar). \**P* \< 0.05, \*\**P* \< 0.01 compared with control group at the same time point \[ANOVA followed by Duncan\'s test for the body weight and ankle circumferences in (**A**) and (**B**), Kruskal--Wallis ANOVA followed by Dunn\'s test for the pain scores in (**C**) and (**D**)\]. ^\#^*P* \< 0.05 compared between two groups from fifth week through ninth week (two-way ANOVA).](nel056f3){#F3}

![Weak TENS treatments reduce pain scores of plantar (**A**) and dorsal (**B**) flexion test in monoarthritic rats induced by intra-articular injection of CFA at right ankle. 100 Hz TENS was administered once-a-week started at 24 h after injection of CFA and lasted for 9 weeks (shown by arrows on the horizontal bar). The weak (1-1-2 mA) TENS treatment induced a decrease in scores of flexion pain test (repeated measures ANOVA on ranks, *P* \< 0.01). TENS treatment with medium intensity (1-2-3 mA) induced a moderate drop of plantar flexion pain test (repeated measures ANOVA on ranks, *P* \< 0.05). \**P* \< 0.05 compared with control group at the same time point (one-way ANOVA on ranks). Note that the vertical bars are presented by median-derived standard error, instead of MADs.](nel056f4){#F4}

![Paralleled observation of the behavioral changes (top panel, **A**--**C**) and spinal SP-ir release (bottom panel, **D**--**F**). Six series of experiments were performed in 13 groups. Behavioral indices were measured and then spinal perfusion was conducted at 1, 2, 3, 5, 7 and 9 weeks after CFA injection. One group of naïve rats served as control. 100 Hz TENS was administered once-a-week started at 24 h after the injection of CFA. The intensity of stimulation was increased from 1 mA to a maximal of 2 mA for 30 min. Behavioral measurements were performed only once for each group prior to spinal perfusion. The inflamed ankles of rats received TENS treatments had a lower level of ankle swelling (A) and lower sensitivity to flexion pain tests (B and C). There was a significant decrease in SP-ir level in spinal perfusate in rats receiving TENS treatments (E and F). \**P* \< 0.05, \*\**P* \< 0.01 compared with the baseline level; ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 compared with the mock TENS control group at the same time point (two-way ANOVA followed by Duncan\'s test for ankle circumference in A, E and F; Kruskal--Wallis ANOVA followed by Dunn\'s test for the pain scores in B and C). ^α^*P* \< 0.05 compared between two groups from second week to ninth week (two-way ANOVA).](nel056f5){#F5}
